United States Interventional Cardiology Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Interventional Cardiology Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Interventional Cardiology Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Interventional Cardiology Overall Market Size
2.1 United States Interventional Cardiology Market Size: 2021 VS 2027
2.2 United States Interventional Cardiology Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Interventional Cardiology Sales: 2016-2027
3 Company Landscape
3.1 Top Interventional Cardiology Players in United States Market
3.2 Top United States Interventional Cardiology Companies Ranked by Revenue
3.3 United States Interventional Cardiology Revenue by Companies
3.4 United States Interventional Cardiology Sales by Companies
3.5 United States Interventional Cardiology Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Interventional Cardiology Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Interventional Cardiology Product Type
3.8 Tier 1, Tier 2 and Tier 3 Interventional Cardiology Players in United States Market
3.8.1 List of Tier 1 Interventional Cardiology Companies in United States
3.8.2 List of Tier 2 and Tier 3 Interventional Cardiology Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Interventional Cardiology Market Size Markets, 2021 & 2027
4.1.2 Cardiology Catheters
4.1.3 Guidewires
4.1.4 Balloon Catheters
4.1.5 Coronary Stents
4.1.6 Fractional Flow Reserve
4.1.7 Intravascular Ultrasound
4.2 By Type - United States Interventional Cardiology Revenue & Forecasts
4.2.1 By Type - United States Interventional Cardiology Revenue, 2016-2021
4.2.2 By Type - United States Interventional Cardiology Revenue, 2022-2027
4.2.3 By Type - United States Interventional Cardiology Revenue Market Share, 2016-2027
4.3 By Type - United States Interventional Cardiology Sales & Forecasts
4.3.1 By Type - United States Interventional Cardiology Sales, 2016-2021
4.3.2 By Type - United States Interventional Cardiology Sales, 2022-2027
4.3.3 By Type - United States Interventional Cardiology Sales Market Share, 2016-2027
4.4 By Type - United States Interventional Cardiology Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Interventional Cardiology Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - United States Interventional Cardiology Revenue & Forecasts
5.2.1 By Application - United States Interventional Cardiology Revenue, 2016-2021
5.2.2 By Application - United States Interventional Cardiology Revenue, 2022-2027
5.2.3 By Application - United States Interventional Cardiology Revenue Market Share, 2016-2027
5.3 By Application - United States Interventional Cardiology Sales & Forecasts
5.3.1 By Application - United States Interventional Cardiology Sales, 2016-2021
5.3.2 By Application - United States Interventional Cardiology Sales, 2022-2027
5.3.3 By Application - United States Interventional Cardiology Sales Market Share, 2016-2027
5.4 By Application - United States Interventional Cardiology Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Medtronic, Inc.
6.1.1 Medtronic, Inc. Corporation Information
6.1.2 Medtronic, Inc. Overview
6.1.3 Medtronic, Inc. Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.1.4 Medtronic, Inc. Interventional Cardiology Product Description
6.1.5 Medtronic, Inc. Recent Developments
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Overview
6.2.3 Boston Scientific Corporation Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.2.4 Boston Scientific Corporation Interventional Cardiology Product Description
6.2.5 Boston Scientific Corporation Recent Developments
6.3 Abbott Vascular
6.3.1 Abbott Vascular Corporation Information
6.3.2 Abbott Vascular Overview
6.3.3 Abbott Vascular Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.3.4 Abbott Vascular Interventional Cardiology Product Description
6.3.5 Abbott Vascular Recent Developments
6.4 MINVASYS S.A.S.
6.4.1 MINVASYS S.A.S. Corporation Information
6.4.2 MINVASYS S.A.S. Overview
6.4.3 MINVASYS S.A.S. Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.4.4 MINVASYS S.A.S. Interventional Cardiology Product Description
6.4.5 MINVASYS S.A.S. Recent Developments
6.5 BIOTRONIK SE and Co. KG
6.5.1 BIOTRONIK SE and Co. KG Corporation Information
6.5.2 BIOTRONIK SE and Co. KG Overview
6.5.3 BIOTRONIK SE and Co. KG Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.5.4 BIOTRONIK SE and Co. KG Interventional Cardiology Product Description
6.5.5 BIOTRONIK SE and Co. KG Recent Developments
6.6 Bard Peripheral Vascular?Inc
6.6.1 Bard Peripheral Vascular?Inc Corporation Information
6.6.2 Bard Peripheral Vascular?Inc Overview
6.6.3 Bard Peripheral Vascular?Inc Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.6.4 Bard Peripheral Vascular?Inc Interventional Cardiology Product Description
6.6.5 Bard Peripheral Vascular?Inc Recent Developments
6.7 TERUMO CORPORATION
6.7.1 TERUMO CORPORATION Corporation Information
6.7.2 TERUMO CORPORATION Overview
6.7.3 TERUMO CORPORATION Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.7.4 TERUMO CORPORATION Interventional Cardiology Product Description
6.7.5 TERUMO CORPORATION Recent Developments
6.8 KANEKA
6.8.1 KANEKA Corporation Information
6.8.2 KANEKA Overview
6.8.3 KANEKA Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.8.4 KANEKA Interventional Cardiology Product Description
6.8.5 KANEKA Recent Developments
6.9 OrbusNeich Medical, BV
6.9.1 OrbusNeich Medical, BV Corporation Information
6.9.2 OrbusNeich Medical, BV Overview
6.9.3 OrbusNeich Medical, BV Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.9.4 OrbusNeich Medical, BV Interventional Cardiology Product Description
6.9.5 OrbusNeich Medical, BV Recent Developments
6.10 Cordis Cashel
6.10.1 Cordis Cashel Corporation Information
6.10.2 Cordis Cashel Overview
6.10.3 Cordis Cashel Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.10.4 Cordis Cashel Interventional Cardiology Product Description
6.10.5 Cordis Cashel Recent Developments
6.11 Kimal Plc
6.11.1 Kimal Plc Corporation Information
6.11.2 Kimal Plc Overview
6.11.3 Kimal Plc Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.11.4 Kimal Plc Interventional Cardiology Product Description
6.11.5 Kimal Plc Recent Developments
6.12 Volcano Corporation
6.12.1 Volcano Corporation Corporation Information
6.12.2 Volcano Corporation Overview
6.12.3 Volcano Corporation Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.12.4 Volcano Corporation Interventional Cardiology Product Description
6.12.5 Volcano Corporation Recent Developments
6.13 Siemens Medical Solutions USA, Inc
6.13.1 Siemens Medical Solutions USA, Inc Corporation Information
6.13.2 Siemens Medical Solutions USA, Inc Overview
6.13.3 Siemens Medical Solutions USA, Inc Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.13.4 Siemens Medical Solutions USA, Inc Interventional Cardiology Product Description
6.13.5 Siemens Medical Solutions USA, Inc Recent Developments
6.14 Lepu
6.14.1 Lepu Corporation Information
6.14.2 Lepu Overview
6.14.3 Lepu Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.14.4 Lepu Interventional Cardiology Product Description
6.14.5 Lepu Recent Developments
6.15 MicroPort
6.15.1 MicroPort Corporation Information
6.15.2 MicroPort Overview
6.15.3 MicroPort Interventional Cardiology Sales and Revenue in United States Market (2016-2021)
6.15.4 MicroPort Interventional Cardiology Product Description
6.15.5 MicroPort Recent Developments
7 United States Interventional Cardiology Production Capacity, Analysis
7.1 United States Interventional Cardiology Production Capacity, 2016-2027
7.2 Interventional Cardiology Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Interventional Cardiology Supply Chain Analysis
9.1 Interventional Cardiology Industry Value Chain
9.2 Interventional Cardiology Upstream Market
9.3 Interventional Cardiology Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Interventional Cardiology Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Interventional Cardiology in United States Market
Table 2. Top Interventional Cardiology Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Interventional Cardiology Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Interventional Cardiology Revenue Share by Companies, 2016-2021
Table 5. United States Interventional Cardiology Sales by Companies, (K Units), 2016-2021
Table 6. United States Interventional Cardiology Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Interventional Cardiology Price (2016-2021) & (US$/Unit)
Table 8. Manufacturers Interventional Cardiology Product Type
Table 9. List of Tier 1 Interventional Cardiology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Interventional Cardiology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Cardiology Catheters
Table 12. Major Manufacturers of Guidewires
Table 13. By Type - United States Interventional Cardiology Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Interventional Cardiology Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Interventional Cardiology Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Interventional Cardiology Sales (K Units), 2016-2021
Table 17. By Type - United States Interventional Cardiology Sales (K Units), 2022-2027
Table 18. By Application - United States Interventional Cardiology Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Interventional Cardiology Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Interventional Cardiology Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Interventional Cardiology Sales (K Units), 2016-2021
Table 22. By Application - United States Interventional Cardiology Sales (K Units), 2022-2027
Table 23. Medtronic, Inc. Corporation Information
Table 24. Medtronic, Inc. Description and Major Businesses
Table 25. Medtronic, Inc. Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 26. Medtronic, Inc. Interventional Cardiology Product
Table 27. Medtronic, Inc. Recent Developments
Table 28. Boston Scientific Corporation Corporation Information
Table 29. Boston Scientific Corporation Description and Major Businesses
Table 30. Boston Scientific Corporation Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 31. Boston Scientific Corporation Interventional Cardiology Product
Table 32. Boston Scientific Corporation Recent Developments
Table 33. Abbott Vascular Corporation Information
Table 34. Abbott Vascular Description and Major Businesses
Table 35. Abbott Vascular Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 36. Abbott Vascular Interventional Cardiology Product
Table 37. Abbott Vascular Recent Developments
Table 38. MINVASYS S.A.S. Corporation Information
Table 39. MINVASYS S.A.S. Description and Major Businesses
Table 40. MINVASYS S.A.S. Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 41. MINVASYS S.A.S. Interventional Cardiology Product
Table 42. MINVASYS S.A.S. Recent Developments
Table 43. BIOTRONIK SE and Co. KG Corporation Information
Table 44. BIOTRONIK SE and Co. KG Description and Major Businesses
Table 45. BIOTRONIK SE and Co. KG Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 46. BIOTRONIK SE and Co. KG Interventional Cardiology Product
Table 47. BIOTRONIK SE and Co. KG Recent Developments
Table 48. Bard Peripheral Vascular?Inc Corporation Information
Table 49. Bard Peripheral Vascular?Inc Description and Major Businesses
Table 50. Bard Peripheral Vascular?Inc Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 51. Bard Peripheral Vascular?Inc Interventional Cardiology Product
Table 52. Bard Peripheral Vascular?Inc Recent Developments
Table 53. TERUMO CORPORATION Corporation Information
Table 54. TERUMO CORPORATION Description and Major Businesses
Table 55. TERUMO CORPORATION Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 56. TERUMO CORPORATION Interventional Cardiology Product
Table 57. TERUMO CORPORATION Recent Developments
Table 58. KANEKA Corporation Information
Table 59. KANEKA Description and Major Businesses
Table 60. KANEKA Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 61. KANEKA Interventional Cardiology Product
Table 62. KANEKA Recent Developments
Table 63. OrbusNeich Medical, BV Corporation Information
Table 64. OrbusNeich Medical, BV Description and Major Businesses
Table 65. OrbusNeich Medical, BV Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 66. OrbusNeich Medical, BV Interventional Cardiology Product
Table 67. OrbusNeich Medical, BV Recent Developments
Table 68. Cordis Cashel Corporation Information
Table 69. Cordis Cashel Description and Major Businesses
Table 70. Cordis Cashel Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 71. Cordis Cashel Interventional Cardiology Product
Table 72. Cordis Cashel Recent Developments
Table 73. Kimal Plc Corporation Information
Table 74. Kimal Plc Description and Major Businesses
Table 75. Kimal Plc Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 76. Kimal Plc Interventional Cardiology Product
Table 77. Kimal Plc Recent Developments
Table 78. Volcano Corporation Corporation Information
Table 79. Volcano Corporation Description and Major Businesses
Table 80. Volcano Corporation Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 81. Volcano Corporation Interventional Cardiology Product
Table 82. Volcano Corporation Recent Developments
Table 83. Siemens Medical Solutions USA, Inc Corporation Information
Table 84. Siemens Medical Solutions USA, Inc Description and Major Businesses
Table 85. Siemens Medical Solutions USA, Inc Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 86. Siemens Medical Solutions USA, Inc Interventional Cardiology Product
Table 87. Siemens Medical Solutions USA, Inc Recent Developments
Table 88. Lepu Corporation Information
Table 89. Lepu Description and Major Businesses
Table 90. Lepu Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 91. Lepu Interventional Cardiology Product
Table 92. Lepu Recent Developments
Table 93. MicroPort Corporation Information
Table 94. MicroPort Description and Major Businesses
Table 95. MicroPort Interventional Cardiology Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
Table 96. MicroPort Interventional Cardiology Product
Table 97. MicroPort Recent Developments
Table 98. Interventional Cardiology Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 99. United States Interventional Cardiology Capacity Market Share of Key Manufacturers, 2019-2021
Table 100. Interventional Cardiology Market Opportunities & Trends in United States Market
Table 101. Interventional Cardiology Market Drivers in United States Market
Table 102. Interventional Cardiology Market Restraints in United States Market
Table 103. Interventional Cardiology Raw Materials
Table 104. Interventional Cardiology Raw Materials Suppliers in United States Market
Table 105. Typical Interventional Cardiology Downstream
Table 106. Interventional Cardiology Downstream Clients in United States Market
Table 107. Interventional Cardiology Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Interventional Cardiology Product Picture
Figure 2. Interventional Cardiology Segment by Type
Figure 3. Interventional Cardiology Segment by Application
Figure 4. United States Interventional Cardiology Market Overview: 2020
Figure 5. United States Interventional Cardiology Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Interventional Cardiology Revenue, 2016-2027 (US$, Mn)
Figure 7. Interventional Cardiology Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Interventional Cardiology Revenue in 2020
Figure 9. Cardiology Catheters Product Picture
Figure 10. Guidewires Product Picture
Figure 11. Balloon Catheters Product Picture
Figure 12. Coronary Stents Product Picture
Figure 13. Fractional Flow Reserve Product Picture
Figure 14. By Type - United States Interventional Cardiology Sales Market Share, 2016-2027
Figure 15. By Type - United States Interventional Cardiology Revenue Market Share, 2016-2027
Figure 16. By Type - United States Interventional Cardiology Price (US$/Unit), 2016-2027
Figure 17. Hospitals
Figure 18. Clinics
Figure 19. Others
Figure 20. By Application - United States Interventional Cardiology Sales Market Share, 2016-2027
Figure 21. By Application - United States Interventional Cardiology Revenue Market Share, 2016-2027
Figure 22. By Application - United States Interventional Cardiology Price (US$/Unit), 2016-2027
Figure 23. Medtronic, Inc. Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Boston Scientific Corporation Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Abbott Vascular Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. MINVASYS S.A.S. Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. BIOTRONIK SE and Co. KG Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Bard Peripheral Vascular?Inc Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. TERUMO CORPORATION Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. KANEKA Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. OrbusNeich Medical, BV Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Cordis Cashel Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Kimal Plc Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Volcano Corporation Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Siemens Medical Solutions USA, Inc Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Lepu Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. MicroPort Interventional Cardiology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. United States Interventional Cardiology Production Capacity (K Units), 2016-2027
Figure 39. Interventional Cardiology Industry Value Chain
Figure 40. Marketing Channels